REXAHN PHARMACEUTICALS INC's ticker is RNN and the CUSIP is 761640101. A total of 35 filers reported holding REXAHN PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $42,000 | +320.0% | 82,391 | +20.3% | 0.00% | – |
| Q4 2016 | $10,000 | -28.6% | 68,500 | 0.0% | 0.00% | – |
| Q3 2016 | $14,000 | -17.6% | 68,500 | -1.2% | 0.00% | – |
| Q2 2016 | $17,000 | -26.1% | 69,312 | 0.0% | 0.00% | – |
| Q1 2016 | $23,000 | +91.7% | 69,312 | +118.3% | 0.00% | – |
| Q4 2015 | $12,000 | -29.4% | 31,748 | 0.0% | 0.00% | – |
| Q3 2015 | $17,000 | 0.0% | 31,748 | +14.3% | 0.00% | – |
| Q2 2015 | $17,000 | -15.0% | 27,783 | 0.0% | 0.00% | – |
| Q1 2015 | $20,000 | +5.3% | 27,783 | +0.5% | 0.00% | – |
| Q4 2014 | $19,000 | +18.8% | 27,658 | +39.3% | 0.00% | – |
| Q3 2014 | $16,000 | -72.4% | 19,860 | -70.0% | 0.00% | – |
| Q2 2014 | $58,000 | -26.6% | 66,123 | -9.1% | 0.00% | – |
| Q1 2014 | $79,000 | +276.2% | 72,733 | +74.2% | 0.00% | – |
| Q4 2013 | $21,000 | +16.7% | 41,755 | +6.3% | 0.00% | – |
| Q3 2013 | $18,000 | +5.9% | 39,286 | 0.0% | 0.00% | – |
| Q2 2013 | $17,000 | – | 39,286 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Northeast Financial Consultants Inc | 150,000 | $109,000 | 0.05% |
| CONDOR CAPITAL MANAGEMENT | 211,371 | $154,000 | 0.04% |
| Benin Management CORP | 83,000 | $61,000 | 0.03% |
| First Heartland Consultants, Inc. | 20,000 | $15,000 | 0.01% |
| Advisory Services Network, LLC | 22,000 | $16,000 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 180,000 | $131,000 | 0.00% |
| Moors & Cabot, Inc. | 11,000 | $7,000 | 0.00% |
| TCI Wealth Advisors, Inc. | 3,000 | $2,000 | 0.00% |
| Corbenic Partners LLC | 1,600 | $1,000 | 0.00% |
| WFG Advisors, LP | 3,500 | $3,000 | 0.00% |